Lista de obras - Nesri Padayatchi - Dominio Público Uruguay

A Moxifloxacin-based Regimen for the Treatment of Recurrent, Drug-sensitive Pulmonary Tuberculosis: An Open-label, Randomized, Controlled Trial

artículo científico publicado en 2020

A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis

artículo científico publicado en 2017

A community officer's perspective of a rural hospital in KwaZulu-Natal ⬇️

artículo científico publicado el 28 de mayo de 2012

Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol

artículo científico publicado en 2017

Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study

artículo científico publicado en 2014

Antibiotic stewardship for drug resistant tuberculosis

scholarly article by Nesri Padayatchi et al published 29 August 2016 in Expert Opinion on Pharmacotherapy

Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infection

scientific article published on 01 March 2019

Association between health systems performance and treatment outcomes in patients co-infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: implications for TB programmes

artículo científico publicado en 2014

Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients

artículo científico publicado en 2020

CAPRISA 003: Timing of Antiretroviral Initiation in HIV-TB Co-infected Patients—The SAPiT Trial

article

Care of the patient with XDR-TB who has failed treatment

artículo científico publicado en 2015

Cellular therapy in tuberculosis

artículo científico

Changes to antiretroviral drug regimens during integrated TB-HIV treatment: results of the SAPiT trial

artículo científico publicado en 2013

Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa

artículo científico publicado en 2015

Correction to: Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol.

artículo científico publicado en 2019

Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy

artículo científico publicado en 2019

Drug-resistant tuberculosis control in South Africa: scientific advances and health system strengthening are complementary

artículo científico publicado en 2014

Drug-resistant tuberculosis in patients with minimal symptoms: favourable outcomes in the absence of treatment.

artículo científico publicado en 2017

Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment

scientific article published on 28 April 2020

Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa

artículo científico publicado en 2018

Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis

artículo científico publicado en 2017

Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB.

artículo científico publicado en 2017

Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis

artículo científico publicado en 2019

Electronic dose monitoring identifies a high-risk subpopulation in the treatment of drug-resistant tuberculosis and HIV

scientific article published on 14 October 2020

Elucidating the role of clofazimine for the treatment of tuberculosis.

artículo científico publicado en 2016

Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials

artículo científico publicado en 2010

Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal

artículo científico publicado en 2015

Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care

artículo científico publicado en 2018

Evolution of extensively drug-resistant tuberculosis over four decades revealed by whole genome sequencing of Mycobacterium tuberculosis from KwaZulu-Natal, South Africa

scholarly article by Keira A. Cohen et al published March 2015 in International journal of mycobacteriology

Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South Africa

artículo científico publicado en 2011

Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance.

artículo científico publicado en 2016

HIV-Associated Tuberculosis

artículo científico publicado en 2010

Health-care workers' perspectives on workplace safety, infection control, and drug-resistant tuberculosis in a high-burden HIV setting

artículo científico publicado en 2013

High Rates of Drug-induced Liver Injury in People Living With HIV Coinfected With Tuberculosis (TB) Irrespective of Antiretroviral Therapy Timing During Antituberculosis Treatment: Results From the Starting Antiretroviral Therapy at Three Points in

scientific article published on 17 October 2019

High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa

scientific article published on 16 November 2020

High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers

artículo científico publicado en 2010

High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa

artículo científico publicado en 2017

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele

artículo científico publicado en 2017

Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals

artículo científico publicado en 2020

Implementation and Operational Research: Clinical Impact of the Xpert MTB/RIF Assay in Patients With Multidrug-Resistant Tuberculosis

artículo científico publicado en 2016

Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial

artículo científico publicado en 2014

Individualised treatment of Multi-Drug Resistant Tuberculosis using Whole Genome Sequencing and Expanded Drug Susceptibility Testing

scientific article published on 08 May 2020

Integrating patients' perspectives into integrated tuberculosis-human immunodeficiency virus health care ⬇️

artículo científico publicado el 11 de febrero de 2013

Integration of antiretroviral therapy with tuberculosis treatment

artículo científico publicado en 2011

Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review

artículo científico publicado en 2019

Justifying research risks in a clinical trial for treatment of multidrug-resistant tuberculosis

artículo científico publicado el 1 de julio de 2011

Lessons from a randomised clinical trial for multidrug-resistant tuberculosis

artículo científico publicado en 2012

MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care.

artículo científico publicado en 2018

Major Depression and Stigma among Individuals with Multidrug-Resistant Tuberculosis in South Africa

scientific article published on 20 July 2020

Major depression and household food insecurity among individuals with multidrug-resistant tuberculosis (MDR-TB) in South Africa

scientific article published on 13 February 2019

Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children.

artículo científico publicado en 2014

Managing multiple and extensively drug-resistant tuberculosis and HIV

article

Mapping the tuberculosis scientific landscape among BRICS countries: a bibliometric and network analysis

artículo científico publicado en 2020

Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa.

artículo científico publicado en 2004

Multidrug-resistant tuberculous meningitis in children in Durban, South Africa

artículo científico publicado en 2006

Neurocognitive Impairment Risk Among Individuals With Multiple Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection: Implications for Systematic Linkage to and Retention of Care in Tuberculosis/Human Immunodeficiency Virus Treatm

scientific article published on 01 April 2019

Paediatric chemoprophylaxis for child contacts of drug-resistant tuberculosis cases: Are current guidelines effective in preventing disease?

artículo científico publicado en 2015

Paediatric chemoprophylaxis for child contacts of patients with drug-resistant tuberculosis: Are current guidelines effective in preventing disease?

Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosis

artículo científico publicado en 2012

Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis

artículo científico publicado en 2020

Precision medicine in resistant Tuberculosis: Treat the correct patient, at the correct time, with the correct drug

artículo científico publicado en 2019

Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa

artículo científico publicado en 2014

Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa

artículo científico publicado en 2015

Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study.

artículo científico publicado en 2016

Pulmonary resection for extensively drug resistant tuberculosis in Kwazulu-Natal, South Africa

artículo científico publicado en 2012

Quality of TB care among people living with HIV: Gaps and solutions

scientific article published on 20 September 2019

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

artículo científico publicado en 2020

Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.

artículo científico publicado en 2016

Recurrent tuberculosis among HIV-coinfected patients: a case series from KwaZulu-Natal

article

Risk of Nephrotoxicity in Patients With Drug-Resistant Tuberculosis Treated With Kanamycin/Capreomycin With or Without Concomitant Use of Tenofovir-Containing Antiretroviral Therapy

artículo científico publicado en 2018

Rural medicine and ‘home stay’: a medical student’s experience

Social constraints to TB/HIV healthcare: Accounts from coinfected patients in South Africa ⬇️

artículo científico publicado el 24 de abril de 2012

Spatial Temporal Clustering of Multi- and Extensively Drug Resistant Tuberculosis is Associated with HIV Status and Drug-susceptibility Pattern in KwaZulu-Natal, South Africa

artículo científico publicado en 2019

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

artículo científico publicado en 2009

Surgical treatment of complications of pulmonary tuberculosis, including drug-resistant tuberculosis

artículo científico

Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.

artículo científico

TB Control in South Africa

article

TB epidemiology: where are the young women? Know your tuberculosis epidemic, know your response.

artículo científico publicado en 2018

The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis

artículo científico publicado en 2010

The World Health Organization excludes Mycobacterium tuberculosis from the 2017 priority pathogens list

article

The contrasting cultures of HIV and tuberculosis care

artículo científico publicado en 2015

The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis

artículo científico publicado en 2005

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

artículo científico publicado en 2017

The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial

artículo científico publicado en 2012

The whole is greater than the sum of the parts: recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa

artículo científico publicado en 2009

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

artículo científico publicado en 2011

Timing of initiation of antiretroviral drugs during tuberculosis therapy

artículo científico publicado en 2010

Towards host-directed therapies for tuberculosis

artículo científico publicado en 2015

Transmission of drug-resistant tuberculosis in HIV-endemic settings

article

Treat the patient, not the result

artículo científico publicado en 2009

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis

artículo científico publicado en 2018

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

scientific article published in The Lancet

Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection

artículo científico publicado en 2013

Tuberculosis Elimination in the Era of COVID-19: A Moving Target

artículo científico publicado en 2020

Tuberculosis: treatment failure, or failure to treat? Lessons from India and South Africa

article

Turning the tide against tuberculosis

scholarly article by Nesri Padayatchi et al published March 2017 in International Journal of Infectious Diseases

Understanding the Profile of Tuberculosis and Human Immunodeficiency Virus Coinfection: Insights from Expanded HIV Surveillance at a Tuberculosis Facility in Durban, South Africa

artículo científico publicado en 2014

Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implications

artículo científico publicado en 2017

Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis.

artículo científico publicado en 2018

XDR-TB in South Africa: no time for denial or complacency

artículo científico publicado en 2007

Lista de obras de Nesri Padayatchi

A Moxifloxacin-based Regimen for the Treatment of Recurrent, Drug-sensitive Pulmonary Tuberculosis: An Open-label, Randomized, Controlled Trial

A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis

A community officer's perspective of a rural hospital in KwaZulu-Natal ⬇️

Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol

Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study

Antibiotic stewardship for drug resistant tuberculosis

Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infection

Association between health systems performance and treatment outcomes in patients co-infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: implications for TB programmes

Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients

CAPRISA 003: Timing of Antiretroviral Initiation in HIV-TB Co-infected Patients—The SAPiT Trial

Care of the patient with XDR-TB who has failed treatment

Cellular therapy in tuberculosis

Changes to antiretroviral drug regimens during integrated TB-HIV treatment: results of the SAPiT trial

Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa

Correction to: Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol.

Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy

Drug-resistant tuberculosis control in South Africa: scientific advances and health system strengthening are complementary

Drug-resistant tuberculosis in patients with minimal symptoms: favourable outcomes in the absence of treatment.

Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment

Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa

Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis

Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB.

Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis

Electronic dose monitoring identifies a high-risk subpopulation in the treatment of drug-resistant tuberculosis and HIV

Elucidating the role of clofazimine for the treatment of tuberculosis.

Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials

Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal

Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care

Evolution of extensively drug-resistant tuberculosis over four decades revealed by whole genome sequencing of Mycobacterium tuberculosis from KwaZulu-Natal, South Africa

Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South Africa

Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance.

HIV-Associated Tuberculosis

Health-care workers' perspectives on workplace safety, infection control, and drug-resistant tuberculosis in a high-burden HIV setting

High Rates of Drug-induced Liver Injury in People Living With HIV Coinfected With Tuberculosis (TB) Irrespective of Antiretroviral Therapy Timing During Antituberculosis Treatment: Results From the Starting Antiretroviral Therapy at Three Points in

High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa

High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers

High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele

Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals

Implementation and Operational Research: Clinical Impact of the Xpert MTB/RIF Assay in Patients With Multidrug-Resistant Tuberculosis

Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial

Individualised treatment of Multi-Drug Resistant Tuberculosis using Whole Genome Sequencing and Expanded Drug Susceptibility Testing

Integrating patients' perspectives into integrated tuberculosis-human immunodeficiency virus health care ⬇️

Integration of antiretroviral therapy with tuberculosis treatment

Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review

Justifying research risks in a clinical trial for treatment of multidrug-resistant tuberculosis

Lessons from a randomised clinical trial for multidrug-resistant tuberculosis

MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care.

Major Depression and Stigma among Individuals with Multidrug-Resistant Tuberculosis in South Africa

Major depression and household food insecurity among individuals with multidrug-resistant tuberculosis (MDR-TB) in South Africa

Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children.

Managing multiple and extensively drug-resistant tuberculosis and HIV

Mapping the tuberculosis scientific landscape among BRICS countries: a bibliometric and network analysis

Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa.

Multidrug-resistant tuberculous meningitis in children in Durban, South Africa

Neurocognitive Impairment Risk Among Individuals With Multiple Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection: Implications for Systematic Linkage to and Retention of Care in Tuberculosis/Human Immunodeficiency Virus Treatm

Paediatric chemoprophylaxis for child contacts of drug-resistant tuberculosis cases: Are current guidelines effective in preventing disease?

Paediatric chemoprophylaxis for child contacts of patients with drug-resistant tuberculosis: Are current guidelines effective in preventing disease?

Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosis

Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis

Precision medicine in resistant Tuberculosis: Treat the correct patient, at the correct time, with the correct drug

Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa

Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa

Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study.

Pulmonary resection for extensively drug resistant tuberculosis in Kwazulu-Natal, South Africa

Quality of TB care among people living with HIV: Gaps and solutions

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.

Recurrent tuberculosis among HIV-coinfected patients: a case series from KwaZulu-Natal

Risk of Nephrotoxicity in Patients With Drug-Resistant Tuberculosis Treated With Kanamycin/Capreomycin With or Without Concomitant Use of Tenofovir-Containing Antiretroviral Therapy

Rural medicine and ‘home stay’: a medical student’s experience

Social constraints to TB/HIV healthcare: Accounts from coinfected patients in South Africa ⬇️

Spatial Temporal Clustering of Multi- and Extensively Drug Resistant Tuberculosis is Associated with HIV Status and Drug-susceptibility Pattern in KwaZulu-Natal, South Africa

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

Surgical treatment of complications of pulmonary tuberculosis, including drug-resistant tuberculosis

Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.

TB Control in South Africa

TB epidemiology: where are the young women? Know your tuberculosis epidemic, know your response.

The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis